Financings In Brief
This article was originally published in The Gray Sheet
Executive Summary
PneumRx raises $33 million for PMA trial
You may also be interested in...
Waiting For Exhale: Emphysema Researchers Call For New Stent Designs, More Analysis
New stent designs and placement techniques are needed to develop an interventional device that successfully treats severe emphysema, researchers said following publication of disappointing study results for a drug-eluting stent system intended to create airway passages in the lung.
Waiting For Exhale: Emphysema Researchers Call For New Stent Designs, More Analysis
New stent designs and placement techniques are needed to develop an interventional device that successfully treats severe emphysema, researchers said following publication of disappointing study results for a drug-eluting stent system intended to create airway passages in the lung.
Macular Degeneration Implant Approval Requires Two Post-Market Studies
VisionCare Ophthalmic Technologies must conduct two post-market studies of its IMT implantable miniature telescope as a condition of its July 1 PMA approval for end-stage age-related macular degeneration (AMD)